Jantoven

Upsher-Smith Laboratories, LLC🇺🇸 United States

FDA Page

Effective Date: Mar 31, 2023
Approval ID: 19a69a72-ac5d-45d5-a94d-a5aaecbe4730
Products: 9 registered
Version: 12

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use JANTOVEN safely and effectively. See full prescribing information for JANTOVEN. Jantoven Tablets (Warfarin Sodium Tablets, USP), for oral use Initial U.S. Approval: 1954

Quick Stats

Total Products9

Labelers2

Label Sections42

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.